Right from the Start: Life Course Approach to Gender Equity in Health

Initial Announcement Right from the Start Right from the Start: Promoting a Life-Course Approach to Gender Equity in Health European Institute of Women’s Health 21st Anniversary Expert Conference European Economic and Social Committee Brussels, Belgium 4-5th December 2017 Details following this week.

Read More

Strep B Awareness Month

PRESS RELEASE In Recognition of Strep B Awareness Month, the European Institute of Women’s Health calls on key stakeholders and citizens of Europe to eliminate preventable Group B Strep transmission to infants 19 July 2017—July is International Group B Strep Awareness Month. This year’s theme, “What if we had known…?” promotes awareness raising of Group…

Read More

Marrakesh Treaty adopted by EU Parliament

..Blind Union Prepare for Fight over Publisher  ‘Compensation’ European Parliament today finally adopted the legal instruments to ratify the Marrakesh Treaty on access to reading material for the visually impaired. The treaty, adopted by the members of the World Intellectual Property Organization in 2013 and effective since last year, was subject to controversies due to…

Read More

Physical activity worldwide reveals an activity inequality

Worldwide activity inequality for women! To help curb the global pandemic of physical inactivity and the resulting 5.3 million deaths per annum, it is necessary to understand the basic principles that govern physical activity. There is a lack of large-scale measurements of physical activity patterns across free-living populations worldwide By leveraging the wide usage of…

Read More

Health Research Award in aspects of Sex and Gender

BIH Excellence Award for Sex and Gender Aspects in Health Research The application deadline is October 15, 2017 The evaluation committee for the award is composed of internationally recognized experts in Gender Medicine and will meet in November. You can find detailed information about the review process and the evaluation criteria on the BIH website:…

Read More

Rare diseases:

Rare diseases: improving access, care and diagnosis People with a rare diseases face challenges as such diseases can take time to be diagnosed.  Patients can go through years of testing and mis diagnosis before seeing a specialist who knows what care they require. About 5% of rare diseases have therapies with few cures, at best…

Read More

eHealth – a tool providing political and economic advantage!

Can eHealth give a political and economic advantage? A study commissioned by Michał Boni,MEP attempts to explore the eHealth development rate among European countries and how various outcomes and solutions might contribute to more cost efficient healthcare systems. The study was presented at the European Parliament (EPPE) on the 8th June 2017. The study authors…

Read More

Protection of Life During Pregnancy Act 2013 – 3rd Annual Report

Press Release from Dept. of Health, Ireland Third Annual Report of notifications in accordance with the Protection of Life During Pregnancy Act 2013 laid before the Houses of the Oireachtas The third annual report on the Protection of Life During Pregnancy Act 2013 has been laid before the Houses of the Oireachtas as required under…

Read More

Use in pregnancy and women of childbearing age of valproate

Review of valproate use in pregnancy and women of childbearing age EMA to consider risks of these medicines require further restrictions of use The European Medicines Agency (EMA) has started a review looking at the use of valproate containing medicines in the treatment of women and girls who are pregnant or of childbearing age. These…

Read More

Final guidance for treating neuroendocrine tumours (NETs)

Guidance issued by NICE (England) for treating neuroendocrine tumours (NETs) Final guidance recommending everolimus (Infinitor, Novartis) and sunitinib (Sutent, Pfizer) to treat neuroendocrine tumours (NETs). The drugs are recommended as an option for pancreatic NETs that cannot be operated on and have progressed. Everolimus is also recommended as an option for those with NETs of…

Read More